ライフサイエンスコーパス: heart catheterization

1 odynamic variables were measured using right-heart catheterization.

2 dynamics underwent subsequent exercise right heart catheterization.

3 re referred for a clinically indicated right heart catheterization.

4 data on IPAH patients who underwent a right heart catheterization.

5 Ten adult patients underwent right- and left-heart catheterization.

6 MRI (MR fluoroscopy) to guide left and right heart catheterization.

7 Ten patients underwent right and left heart catheterization.

8 PCWP was measured with right heart catheterization.

9 P <.05) in the 6 patients restudied by right-heart catheterization.

10 lmonary hypertension was determined by right-heart catheterization.

11 ured by both echocardiography and right/left heart catheterization.

12 with pulmonary hypertension underwent right heart catheterization.

13 s, transthoracic echocardiography, and right heart catheterization.

14 on pre-LVAD hemodynamics obtained via right heart catheterization.

15 gitation velocity 2.5 m/s proceeded to right heart catheterization.

16 ercise (25 W), and peak exercise using right heart catheterization.

17 with PH-HFpEF obtained at the time of right heart catheterization.

18 echocardiography and were obtained by right heart catheterization.

19 tained simultaneously with direct Fick right heart catheterization.

20 s underwent additional exercise stress right heart catheterization.

21 ed of pulmonary hypertension underwent right heart catheterization.

22 s HFpEF or noncardiac dyspnea based on right heart catheterization.

23 nce of up to 78% in those referred for right-heart catheterization.

24 PCWP >= 25 mm Hg, n = 13) according to right heart catheterization.

25 raphy scans performed within 2 days of right heart catheterization.

26 ng Optical Coherence Tomography during Right Heart catheterization.

27 ion, but definitive diagnosis requires right-heart catheterization.

28 or (3) inpatient status at the time of right heart catheterization.

29 with unexplained dyspnea who underwent right heart catheterization.

30 technique in adult patients undergoing right heart catheterization.

31 35 mm Hg on echocardiogram underwent a right heart catheterization.

32 al telopeptide of type I collagen) and right heart catheterization.

33 y implanted in all participants during right heart catheterization.

34 y rise in right atrial pressure during right heart catheterization.

35 o vasodilator testing require invasive right heart catheterization.

36 luated with serial echocardiograms and right heart catheterizations.

37 ospectively all US veterans undergoing right heart catheterization (2007-2012) in the Veterans Affair

38 In patients with right heart catheterization (30 HF-PH, 14 PVOD), similar assoc

39 e 41 patients with abnormal MPI, 18 had left heart catheterization (9 were false-positive); there wer

40 Patients were classified by right heart catheterization according to current guideline rec

41 diologists were more likely to undergo right-heart catheterization (adjusted odds ratio, 2.9 [CI, 1.7

42 included outcomes among patients with right heart catheterization after the first echocardiogram, wi

43 Hemodynamic values from right heart catheterization aid diagnosis and clinical decisio

44 apillary wedge pressure </=15 mm Hg at right heart catheterization (allele frequency, 0.66; odds rati

45 t patients, five of which had multiple right heart catheterizations allowing an assessment of cardiac

46 not universally detectable by resting right heart catheterization alone and call for further study o

47 fine LV pressure-volume relationships, right heart catheterization and 3-dimensional echocardiography

48 dian age, 58.9 years]) underwent right-sided heart catheterization and 3-T CE cardiac MR imaging.

49 own or suspected to have PAH underwent right heart catheterization and adenosine stress MR imaging on

50 t, 35 PAH patients were evaluated with right heart catheterization and cardiac magnetic resonance (MR

51 Patients underwent right heart catheterization and cardiac magnetic resonance ima

52 ith pulmonary arterial hypertension by right heart catheterization and cardiac magnetic resonance ima

53 vivo measurements were assessed using right heart catheterization and cardiac MRI.

54 nts underwent rest and exercise-stress right heart catheterization and cardiovascular magnetic resona

55 Patients referred to both right heart catheterization and cardiovascular magnetic resona

56 om 60 COPD patients who underwent both right heart catheterization and computed tomography in a perio

57 red for diagnostic evaluation underwent left heart catheterization and coronary angiography from the

58 vely evaluated 53 PPH patients who had right heart catheterization and cycle ergometer CPET studies t

59 tive patients, undergoing simultaneous right heart catheterization and DE.

60 Simultaneous left heart catheterization and Doppler echocardiography (DE)

61 of congestive heart failure underwent right heart catheterization and Doppler-echocardiography to me

62 cutive participants who underwent both right heart catheterization and dual-phase dual-energy CT pulm

63 In 50 patients with simultaneous right heart catheterization and echocardiographic imaging, mit

64 ars, 19 women) undergoing simultaneous right heart catheterization and echocardiographic imaging, wit

65 Nine of the 16 patients underwent right heart catheterization and echocardiography during bicycl

66 horatec Inc; n=18) were evaluated with right heart catheterization and echocardiography preoperativel

67 Right-heart catheterization and echocardiography were performe

68 Right heart catheterization and echocardiography were performe

69 cycle ergometer test with simultaneous right heart catheterization and echocardiography.

70 pants undergoing simultaneous right and left heart catheterization and estimated associations of eGFR

71 atients who underwent first diagnostic right heart catheterization and from a prospective cohort of 8

72 essed with invasive procedures such as right heart catheterization and histopathology.

73 maging within 24 hours of a diagnostic right heart catheterization and invasive measurement of RV pre

74 after therapy; patients also underwent right-heart catheterization and LSM at these time points.

75 y underwent detailed reassessment with right heart catheterization and noninvasive testing at 3 to 6

76 All measurements, including data from right heart catheterization and norepinephrine requirements, w

77 ve physiological assessment with right-sided heart catheterization and radionuclide ventriculography

78 dergoing clinically indicated left and right heart catheterization and same day research cardiac magn

79 ary edema, invasive techniques such as right heart catheterization and the sampling of alveolar fluid

80 Hemodynamic variables obtained by right heart catheterization and transpulmonary thermodilution

81 mic evaluation was performed by serial right heart catheterization and transthoracic echocardiography

82 ters who had PH-ILD confirmed by right-sided heart catheterization and who received targeted PAH ther

83 bolic pulmonary hypertension underwent right heart catheterization and-after digital subtraction angi

84 The 25 HOCM patients had left heart catheterization, and 16 were re-examined after sep

85 magnetic resonance (MR) imaging, right-sided heart catheterization, and 6-minute walk testing with a

86 cular pressure-volume loop recordings, right heart catheterization, and arterial and mixed venous blo

87 tress testing, cardiology consultation, left heart catheterization, and cardiac revascularization wit

88 vely enrolled with follow-up clinical, right heart catheterization, and echocardiographic evaluations

89 ho had coronary physiology assessment, right heart catheterization, and echocardiography performed at

90 left ventricular hypertrophy, previous left heart catheterization, and higher exposure to dialysis.

91 monstrated any sustained benefits from right heart catheterization, and some studies have even sugges

92 ion," "Swan-Ganz catheterization" and "right heart catheterization," and restricting the results to "

93 A Supright exercise right heart catheterization approach is feasible and merits fu

94 ctors using systematic confirmation on right heart catheterization are lacking.

95 Echocardiography and right heart catheterization are the principal modalities for t

96 tudies, including echocardiography and right heart catheterization, are key elements in the assessmen

97 lar ejection fraction <=45% undergoing right heart catheterization as part of advanced heart failure

98 CS]) in 9 patients undergoing right and left heart catheterization as part of their CHF assessment (a

99 roduct was also determined by means of right heart catheterization, as an index of the RV MVO2, and w

100 PAH (81% idiopathic) with a follow-up right heart catheterization at 6 months (interquartile range,

101 All patients underwent right heart catheterization at baseline and were followed for

102 onstrated by pulmonary hypertension at right-heart catheterization at days 21 to 35 and major remodel

103 Patients underwent right heart catheterization at rest and during exercise at bas

104 Patients underwent right-heart catheterization at rest and during exercise at bas

105 went simultaneous echocardiography and right heart catheterization at rest and during exercise.

106 tomatic, severe AS were evaluated with right heart catheterization at rest and during moderate exerci

107 s; n=14 HFpEF; n=12 control) underwent right heart catheterization at rest, during supine exercise, a

108 ejection fraction <=45%) who underwent right heart catheterization at The Department of Cardiology at

109 y in 43 patients with HFpEF undergoing right heart catheterization at the University of Michigan, and

110 the basis of PC-MRI in comparison with right heart catheterization-based measurements by a median of

111 ue Doppler imaging, simultaneously with left heart catheterization before and after NSRT.

112 ty-six patients underwent preoperative right heart catheterization before PTE.

113 l status for all patients referred for right heart catheterization between 1998 and 2014.

114 ients with heart failure who underwent right heart catheterization between 2000 and 2005.

115 amined consecutive patients undergoing right heart catheterization between 2005 and 2016 in a hospita

116 We examined patients undergoing right heart catheterization between 2005 and 2016 in a hospita

117 Using the index right heart catheterization between 2010 and 2016, we calculat

118 sis of simultaneous left-side and right-side heart catheterizations between January 2006 and January

119 sed mean pulmonary artery pressure (on right heart catheterization), by 0.27 mm Hg (0.27; 95% CI: 0.0

120 ion [n=6]) were evaluated monthly with right heart catheterization, CMR, and computed tomography duri

121 y cohort and a sex-balanced validation right heart catheterization cohort from Vanderbilt University.

122 ohorts based on the date of diagnostic right heart catheterization: cohort A included patients whose

123 Right heart catheterization confirmed constrictive physiology

124 Also, right heart catheterization confirmed higher right atrial pres

125 nts were stratified by current resting right heart catheterization criteria, and in a separate analys

126 We analyze left heart catheterization data alongside simultaneous brachi

127 Laboratory, echocardiography, and right heart catheterization data collected from 205 patients b

128 Right heart catheterization data from clinical records of hear

129 ess syndrome who had complete baseline right heart catheterization data from the Fluid and Catheter T

130 t failure, we retrospectively assessed right heart catheterization data in 162 consecutive patients w

131 ak VO2 outperforms clinical variables, right-heart catheterization data, exercise time, and other exe

132 f PH and is hemodynamically defined by right heart catheterization demonstrating a mean pulmonary art

133 regarding the utility of preoperative right heart catheterization-derived parameters in patients und

134 Right heart catheterization-derived parameters offer insights

135 between screening echocardiography and right heart catheterization determinations of pressure, flow,

136 ry wedge pressure waveform obtained by right-heart catheterization during 5 different loading conditi

137 8 to 2016 from a single center and had right heart catheterizations during the procedure.

138 invasive hemodynamic ramp testing with right heart catheterization, during which LVAD speeds were adj

139 eatment period, participants underwent right heart catheterization, echocardiography, and blood sampl

140 h treatment period, patients underwent right heart catheterization, echocardiography, and blood sampl

141 Right heart catheterization evaluated hemodynamics.

142 patients undergoing left-side and right-side heart catheterization for assessment of CP after noninva

143 ass III or IV symptomatology underwent right heart catheterization for determination of baseline hemo

144 Patients undergoing right heart catheterization for evaluation of pulmonary hypert

145 rolling patients referred for exercise right heart catheterization for HFpEF.

146 Of 3702 patients undergoing right heart catheterization for PAH diagnosis, 2051 had idiopa

147 ior vena cava and hepatic veins during right heart catheterization from 3 groups of patients: (1) con

148 rillation included corticosteroid use, right heart catheterization, fungal infection, vasopressor use

149 ne-derived radioactivity who underwent right-heart catheterization had a decreased cardiac extraction

150 ic techniques for the determination of right heart catheterization hemodynamic variables in patients

151 Patients underwent right heart catheterization immediately followed by transthora

152 phy were performed simultaneously with right-heart catheterization in 51 consecutive patients (mean+/

153 The significance of right heart catheterization in critically ill patients is cont

154 hocardiography and following up with a right heart catheterization in patients in whom the right vent

155 odynamic changes with accuracy equivalent to heart catheterization in patients with aortic coarctatio

156 routine use of fluid challenge during right heart catheterization in patients with risk factors for

157 arameters and hemodynamics obtained by right heart catheterization in PH with AF.

158 e and may obviate the need for routine right heart catheterization in potential heart transplant cand

159 ings support the role of comprehensive right heart catheterization in preprocedural risk stratificati

160 e of exercise-induced PH determined by right heart catheterization in scleroderma spectrum disorders.

161 tics of echocardiography compared with right heart catheterization in the determination of systolic p

162 ry artery pressure (mPAP) diagnosed by right heart catheterization in the U.S. Veterans Affairs syste

163 We studied 233 patients assigned to right heart catheterization in the Vasodilation in the Managem

164 9.9] years; 3.3% female) who underwent right heart catheterization in this cohort study, Td and eFick

165 pulmonary hypertension (documented by right heart catheterization) in a multicenter, randomized, dou

166 e more than 15000 adults who underwent right heart catheterization, including 12232 in the Veterans A

167 base, RSW was superior to conventional right heart catheterization indices at assessing risk of morta

168 They also underwent right-heart catheterization, intra-aortic balloon pumping and

169 Invasive exercise right heart catheterization is a gold standard in diagnosing h

170 Exercise right heart catheterization is considered the gold standard an

171 1950s of the transseptal technique for left heart catheterization is described.

172 Fluid challenge at the time of right heart catheterization is easily performed, safe, and ide

173 In conclusion, right heart catheterization is necessary to confirm POPH and f

174 However, performing exercise during right heart catheterization is not universally available.

175 Diagnosis is made when heart catheterization is performed in the work up for ac

176 Right heart catheterization is the gold standard for assessmen

177 Cardiac output measurement via right heart catheterization is used extensively for hemodynami

178 urgery within 72 hours after diagnostic left heart catheterization (LHC; primary end point).

179 A total of 469 CA patients underwent right heart catheterization (light chain CA=42% and transthyre

180 ), acute vasoreactivity testing during right heart catheterization may identify acute vasoresponders,

181 Twenty patients with PH underwent right heart catheterization: mean pulmonary artery pressure 38

182 Right heart catheterization measured pulmonary capillary wedge

183 Pericardial tamponade was suggested by right heart catheterization measurements and diagnosed by echo

184 e heart transplant recipients analyzed right heart catheterization measurements, inotrope scores, ech

185 Using right heart catheterization measurements, mild PH was defined

186 ive transthoracic echocardiography and right heart catheterization measurements.

187 simultaneously measured mPAP) and with right heart catheterization measurements.

188 , patient demographic characteristics, right heart catheterization, mechanical circulatory support us

189 ressures at echocardiography and right-sided heart catheterization, medications, chronic lung disease

190 Among patients with right heart catheterization (n=61), PH was present in 51 (83.6

191 patients were divided into 2 groups by right heart catheterization: no PH (mean pulmonary artery pres

192 emodynamic parameters obtained through right heart catheterization on patient-centered outcomes.

193 (OR, 3.7 [95% CI, 3.1-4.4]) and prior right heart catheterization (OR, 3.8 [95% CI, 3.4-4.3]).

194 e models of pertussis by Fulton index, right heart catheterization, or Doppler echocardiogram.

195 PCWP (right heart catheterization), oxygen uptake (breath x breath g

196 ring interventional procedures such as right heart catheterization, pacemaker implantation, invasive

197 r assessment of transvalvular flow and right heart catheterization performed during pacing at AV dela

198 Right heart catheterization plays a pivotal role in the prepro

199 nvasive hemodynamic evaluation through right heart catheterization plays an essential role in the dia

200 the PVDOMICS study, the comprehensive right heart catheterization protocol described here holds prom

201 05]; AOR, 0.57; 95% CI, 0.49-0.67), and left heart catheterization rates (1.0% [198 of 19 103] vs 1.2

202 ss in echocardiography and biomarkers, right heart catheterization remains the only test that can dia

203 for elevated troponins, and subsequent left heart catheterization revealed findings consistent with

204 diagnosed with PHT, who underwent both right heart catheterization (RHC) and CT, were enrolled as a c

205 Correlation with same-day right heart catheterization (RHC) and scan-rescan repeatabilit

206 tients with normal mPAP) who underwent right heart catheterization (RHC) and three-directional phase-

207 Analysis of data from right heart catheterization (RHC) and transthoracic echocardio

208 lmonary hypertension (PH) diagnosed by right heart catheterization (RHC) are independent risk factors

209 hypertension (PH), with same-day right-side heart catheterization (RHC) as the reference standard.

210 PH who underwent cardiac MRI and right-sided heart catheterization (RHC) between 2012 and 2016 were r

211 ansthoracic echocardiography (TTE) and right heart catheterization (RHC) data was used to identify ke

212 Right heart catheterization (RHC) is commonly performed before

213 Right heart catheterization (RHC) is commonly used in the diag

214 Right heart catheterization (RHC) must be performed in patient

215 Right heart catheterization (RHC) plays a pivotal role across

216 llowed for the outcome of undergoing a right heart catheterization (RHC) used as a surrogate marker o

217 oven sarcoidosis and SAPH confirmed by right heart catheterization (RHC) were identified from 1990-20

218 -walk testing, V/Q scanning, CTPA, and right heart catheterization (RHC) were prospectively obtained.

219 Suspected HF patients underwent right heart catheterization (RHC), CMR and transthoracic echoc

220 ld phase-contrast MR imaging and right-sided heart catheterization (RHC).

221 PAP) value of at least 25 mm Hg during right heart catheterization (RHC).

222 006 and 2016 who had a follow-up right-sided heart catheterization (RHC).

223 nt patients are followed with periodic right heart catheterizations (RHCs) to identify post-transplan

224 We suggest that right heart catheterization should be reserved for patients wi

225 Right heart catheterization showed severe precapillary PH with

226 At the time of right and left heart catheterization, stents were placed in pulmonary a

227 thetized rat with a recently developed right-heart catheterization technique.

228 of variables collected during resting right heart catheterization that best predicted abnormal exerc

229 with advanced heart failure undergoing right heart catheterization to assess cardiac transplantation

230 cic echocardiography further underwent right heart catheterization to confirm the diagnosis of PAH (m

231 Subjects underwent right heart catheterization to define LV pressure-volume curve

232 nvasive haemodynamic measurements with right heart catheterization to define Starling and left ventri

233 Sixty healthy subjects underwent right heart catheterization to measure age- and sex-related no

234 Right heart catheterization using exercise stress is the refer

235 Left and right heart catheterization using MR guidance is feasible.

236 phic variables, echocardiographic variables, heart catheterization variables, and specific details on

237 al baseline characteristics, including right heart catheterization variables, were not consistently a

238 Diagnosis was confirmed by right heart catheterization, ventilation-perfusion lung scinti

239 medical therapy with a sham procedure (right heart catheterization) versus medical therapy and PFO cl

240 The confirmed PAH prevalence on right heart catheterization was 2.1% (95% confidence interval

241 a-thalassemia patients as confirmed on right heart catheterization was 2.1%, with an approximately 5-

242 The PCWP obtained from right heart catheterization was compared with diastolic indice

243 Right heart catheterization was employed in one study to ident

244 Right heart catheterization was performed and serum uric acid

245 Right heart catheterization was performed before and after cin

246 Right heart catheterization was performed immediately after Do

247 Left and right heart catheterization was performed in 7 swine without t

248 To investigate this hypothesis, right heart catheterization was performed in eight males from

249 (<1 degrees C heating) and MRI-guided right heart catheterization was performed in seven study parti

250 Right heart catheterization was performed using a pressure and

251 ified 12 (71%) of 19 patients for whom right heart catheterization was unnecessary.

252 Using right-heart catheterization, we evaluated the acute pulmonary

253 hain-CA or transthyretin CA undergoing right heart catheterization were analyzed.

254 re aortic stenosis and a preprocedural right heart catheterization were assessed.

255 PAH or ILD-associated PH confirmed by right heart catheterization were included in the study.

256 undergoing a first diagnostic right and left heart catheterization were included in this study.

257 pler echocardiographic examination and right-heart catheterization were performed in 44 patients.

258 eadmill testing, echocardiography, and right heart catheterization were performed.

259 Echocardiography and right heart catheterization were performed.

260 ndividuals scheduled for a left and/or right heart catheterization were prospectively enrolled in thi

261 Simultaneous echocardiography and right heart catheterization were prospectively performed in 50

262 ance (PVR) > 400 dyn s cm(-5) based on right heart catheterization were randomized to treatment with

263 For patients with abnormal MPI, left heart catheterization were reviewed if performed.

264 ansient RBBB pattern in lead V1 during right heart catheterization were studied.

265 ult patients with PAH with two or more right heart catheterizations were identified from a multiinsti

266 t 1, 2, 3, 4, 6, 9, and 12 months) and right heart catheterizations were performed after LVAD implant

267 ft ventricular (LV) filling pressures (right heart catheterization) were measured under varying prelo

268 who underwent 4D flow MRI and invasive right heart catheterization with a shunt run between August 20

269 all patients who received a diagnostic right heart catheterization with PCWP-measurements at rest, PL

270 rwent simultaneous echocardiography and left heart catheterization with pressure-conductance instrume

271 Right-heart catheterization, with its associated disadvantages

272 with transthoracic echocardiogram and right heart catheterization within 1 year.

273 subjects with hemodynamics measured by right heart catheterization within 30 days before left ventric

274 SPECT myocardial perfusion imaging and right heart catheterization within 4 wk were studied prospecti

275 thesized that a fluid challenge during right heart catheterization would identify occult pulmonary ve